Preprint Essay Version 1 This version is not peer-reviewed

Early Detection is as Important as Imatinib in CML Treatment Success

Version 1 : Received: 16 October 2019 / Approved: 18 October 2019 / Online: 18 October 2019 (07:18:47 CEST)

How to cite: Sonkin, D.; Simon, R. Early Detection is as Important as Imatinib in CML Treatment Success. Preprints 2019, 2019100207 (doi: 10.20944/preprints201910.0207.v1). Sonkin, D.; Simon, R. Early Detection is as Important as Imatinib in CML Treatment Success. Preprints 2019, 2019100207 (doi: 10.20944/preprints201910.0207.v1).

Abstract

Chronic myelogenous leukemia (CML) was the first malignancy for which clinical outcome was drastically improved by kinase inhibitor therapy. Kinase inhibitors targeting other well-known oncogenes have been introduced into clinical practice, but none have shown the same magnitude of clinical benefit as ABL1 inhibition in CML. We argue that early detection is an underappreciated, but critically important factor in success of ABL1 inhibitors in treatment of CML. We show that CML provides a window into how many types of cancer may look and behave at an early stage, prior to diagnosis and the development of additional genomic alterations. The remarkable clinical benefits of ABL1 inhibition is likely due to early detection of CML at a stage in which the tumor is driven by single oncogenic alteration which can be successfully controlled by the inhibitor. Thinking of CML as a prototype for effective systemic treatment based on early cancer detection may help to develop strategies for improving treatment for other types of cancer.

Subject Areas

CML; Imatinib; early detection; cancer; tumor progression; oncology; Gleevec; Glivec

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.